Arguably, the development and approval of Menin Inhibitors in AML are one of the most important advances in this disease in the past 1-2 years. Dr. Uma Borate joins Healthcare Unfiltered EXPRESS and shares with us everything we must know about this class of drugs: how they are used, their toxicities, and what the future of AML management may look like now that we have Menin inhibitors. Check it out, subscribe, and review.